Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Toby Cole

Diagnostic Radiology Asheville, NC Medical Doctor

NPI 1417998089 CMS profile 291543

222 Asheland Ave, Asheville, NC 28801

Open in the dashboard

General payments

$10,144

153 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Toby Cole of Asheville, NC is reported in the CMS Open Payments database as having received $10,144 across 153 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,177 21
2024 General $2,230 34
2023 General $4,136 63
2022 General $787 18
2021 General $619 10
2020 General $71 3
2019 General $125 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Toby Cole
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Toby Cole were reported at $2,177. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Toby Cole Diagnostic Radiology median Middle half National median
2019 $125 $108 $29–$318 $163
2020 $71 $65 $21–$252 $114
2021 $619 $92 $24–$292 $132
2022 $787 $104 $29–$294 $149
2023 $4,136 $110 $29–$337 $160
2024 $2,230 $113 $30–$356 $164
2025 $2,177 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Inari Medical, Inc. $5,062 105 payments
  2. AngioDynamics, Inc. $3,623 7 payments
  3. Stryker Corporation $452 15 payments
  4. Shockwave Medical, Inc $180 1 payment
  5. Philips Electronics North America Corporation $119 2 payments
  6. Tactile Systems Technology Inc $118 5 payments
  7. Cook Medical LLC $93 1 payment
  8. Surmodics, Inc. $90 1 payment
  9. Bard Peripheral Vascular, Inc. $69 2 payments
  10. Cardiva Medical, Inc. $57 2 payments
  11. Other $282 12 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,728 144 payments
  2. Long term medical supply or device loan $3,538 3 payments
  3. Travel and Lodging $2,379 5 payments
  4. Honoraria $500 1 payment
Products named General payments · program years 2019–2025
  1. FLOWTRIEVER CATHETER, S $5,443 111 payments
  2. CT THROMBECTOMY SYSTEM KIT $4,697 101 payments
  3. VenaCure 1470 Pro Et $1,938 2 payments
  4. VenaCure 1470 Pro Id $1,600 1 payment
  5. ARTIX MT $184 2 payments
  6. Vascular Lithotripsy $180 1 payment
  7. FLOWTRIEVER $137 6 payments
  8. Flexitouch Plus $118 5 payments
  9. ZILVER PTX $93 1 payment
  10. (6582) Visions 035 $92 1 payment
  11. Other $955 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Interventional Radiology: 38

Drug cost

$60

Median for Interventional Radiology: $333

Branded share of claims

100%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 14 $60

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 176 billing codes

Paid by Medicare

$112,091

Medicare's payments for the services billed

Medicare patients

1,321

Average age 75

Services billed

2,063

692 women, 629 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Ischemic heart disease 38%
Chronic kidney disease 37%
Diabetes 36%
Depression 34%
Heart failure 31%
Atrial fibrillation 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

153 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record